SCHEMBL7456117

SCHEMBL7456117

CCCCN(N)C=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1448413 0.92
SCHEMBL27545094 0.90 ADH1C (0.48)
SCHEMBL27426586 0.90 ADH1C (0.48)
SCHEMBL8414754 0.90 ADH1C (0.48)
SCHEMBL27990968 0.90 ADH1C (0.48)
SCHEMBL1449127 0.83
SCHEMBL6704525 0.72
SCHEMBL26772 0.72 TSHR (0.41)
Bromide SCHEMBL28362232 0.72
SCHEMBL19220259 0.72

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104780761-A Use of substituted 2, 3-dihydro-1-benzofuran-4-carboxylic acids or salts thereof as active substances against abiotic plant stress BAYER CROPSCIENCE AG 2015-07-15 CN claimed
CN-101711156-A Chirally pure isomers of itraconazole and inhibitors of lanosterol 14A-demethylase for use as angiogenesis inhibitors UNIV JOHNS HOPKINS 2010-05-19 CN claimed
CN-117693500-A Carboxamide derivative and agricultural/horticultural plant disease control agent 组合化学工业株式会社 2024-03-12 CN disclosed
CN-109970669-A A kind of preparation method of the midbody compound of Itraconazole 上海医药工业研究院 2019-07-05 CN disclosed
CN-105814049-B Fused tricyclic imdazole derivatives as TNF active regulator UCB生物制药私人有限公司 2019-03-12 CN disclosed
CN-105452398-B Composition for ink, ink jet recording method and tingle body using this composition for ink 日本化药株式会社 2018-07-10 CN disclosed
CN-105814049-A Fused tricyclic imidazole derivatives as modulators of TNF activity UCB生物制药私人有限公司 2016-07-27 CN disclosed
CN-104936962-A Therapeutically active oxazoline derivatives UCB PHARMA SA 2015-09-23 CN disclosed
CN-104780761-A Use of substituted 2, 3-dihydro-1-benzofuran-4-carboxylic acids or salts thereof as active substances against abiotic plant stress BAYER CROPSCIENCE AG 2015-07-15 CN disclosed
CN-104619709-A Imidazopyridine derivatives as modulators of TNF activity UCB PHARMA SA 2015-05-13 CN disclosed
CN-104470924-A Imidazopyrazine derivatives as modulators of tnf activity UCB PHARMA SA 2015-03-25 CN disclosed
EP-0947510-B1 Process for the preparation of 1,3,4-trisubstituted 1,2,4-triazolium salts BASF AG (DE) 2002-02-13 EP disclosed
CN-1274724-A Preparation method of 8-cyclopentyl-6-ethyl-3- [ substituted ] -5, 8-dihydro-4H-1, 2,3A,7, 8-pentaaza-asymmetric indacene and intermediate thereof PFIZER PRODUCTS CO (US) 2000-11-29 CN disclosed
CN-1264384-A Fused 1,2,4-thiadiazine derivatives, their preparation method and use NOVO NORDISK AS (DK) 2000-08-23 CN disclosed
EP-0947510-A1 Process for the preparation of 1,3,4-trisubstituted 1,2,4-triazolium salts BASF AKTIENGESELLSCHAFT (DE) 1999-10-06 EP disclosed
CN-1222910-A 1,2, 4-benzothiadiazine derivatives, method for preparing same and use thereof NOVO NORDISK AS (DK) 1999-07-14 CN disclosed
CN-1104412-A Peripheral Vasodilating agent containing N-acylated 4-amino piperidine derivatives as active ingredients OTSUKA PHARMA CO LTD (JP) 1995-06-28 CN disclosed
US-4753925-A Antibacterial 1,7-diamino-1,4-dihydro-4-oxo-3-quinolinecarboxylic acids BAYER AKTIENGESELLSCHAFT (DE) 1988-06-28 US disclosed
EP-0155587-B1 1,7-DIAMINO-1,4-DIHYDRO-4-OXO-3(AZA)QUINOLINE-CARBOXYLIC ACIDS, PROCESS FOR THEIR PREPARATION AND THEIR USE IN TREATING BACTERIAL DISEASES BAYER AG (DE) 1988-06-08 EP disclosed
EP-0155587-A1 1,7-Diamino-1,4-dihydro-4-oxo-3(aza)quinoline-carboxylic acids, process for their preparation and their use in treating bacterial diseases BAYER AG (DE) 1985-09-25 EP disclosed